MAVERICK2 MONORAIL PTCA CATHETER
Report
- Report Number
- 2134265-2008-02654
- Event Type
- Injury
- Date Received
- September 16, 2008
- Date of Event
- May 3, 2006
- Report Date
- August 21, 2008
- Manufacturer
- BOSTON SCIENTIFIC
- Product Code
- LOX
- PMA / PMN Number
- P860019/S179
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
DEVICE EVAL: THE COMPLAINANT INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVAL; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFO FROM THIS REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED.
CLINICAL REGISTRY. IT WAS REPORTED THAT DURING A CORONARY ARTERY DRUG-ELUTING STENTING TREATMENT PROCEDURE, A DISSECTION OCCURRED. PRIOR TO THE EVENT, THE PHYSICIAN SUCCESSFULLY TREATED LESIONS IN THE PROXIMAL CIRCUMFLEX AND PROXIMAL RIGHT CORONARY ARTERY (RCA) WITHOUT DIFFICULTIES. NEXT, THE PHYSICIAN TREATED A BIFURCATED LESION IN THE DISTAL RCA/INFERIOR SEPTAL ARTERY. THE LESION MEASURED 3.0X32MM, WAS 80% STENOSED WITH MODERATE CALCIFICATION. THE LESION WAS PRE-DILATED WITH A 2.50X15MM MAVERICK BALLOON. DURING PRE-DILATATION A TYPE B DISSECTION OCCURRED. THE PHYSICIAN ATTEMPTED TO TREAT THE LESION WITH A 3.0X32MM TAXUS LIBERTE STENT, HOWEVER, IT WOULD NOT CROSS THE LESION. THE PHYSICIAN WAS ABLE TO CROSS WITH A 3.00X20MM TAXUS LIBERTE STENT. ADDITIONALLY, THE PHYSICIAN PLACED A 3.00X12MM TAXUS LIBERTE BAILOUT STENT IN THE INFERIOR SEPTAL ARTERY. FOLLOWING TREATMENT, RESIDUAL STENOSIS WAS 10% WITH TIMI - 3 FLOW. THE PT WAS DISCHARGED THE FOLLOWING DAY ON CLOPIDOGREL AND ASPIRIN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | MAVERICK2 MONORAIL PTCA CATHETER | LOX CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS | LOX | BOSTON SCIENTIFIC |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |